Assinatura por 2 €

Institutional-grade intelligence for professional investors

LIVE

•Real-time feeds•Global markets•24/7 coverage

BridgeBio Pharma Aktie News & Pressemeldungen

Notícias Eulerpool BridgeBio Pharma

30/08/2024, 19:43:09

Marktzugang für neues Medikament in Aussicht: BridgeBios Acoramidis zeigt vielversprechende Ergebnisse bei ATTR-CM

23/11/2024, 02:51:48

Brücke in neue Therapie: BridgeBio betritt den Herzmarkt

25/11/2024, 13:35:52

Brücke zu neuen Therapien: FDA genehmigt Attruby von BridgeBio

25/11/2024, 13:47:42

FDA erteilt BridgeBio grünes Licht für Attruby: Ein Durchbruch in der Kardiomyopathie-Behandlung

25/11/2024, 17:22:15

Attruby: BridgeBio setzt zum Schlagabtausch mit Pfizer

1

2

1

2

BridgeBio Pharma Notícias de ações

BridgeBio Pharma é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de BridgeBio Pharma nós reunimos aqui.

6 de agosto ·
Yahoo
Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics
6 de agosto ·
Yahoo
BridgeBio Pharma Inc (BBIO) Q2 2025 Earnings Call Highlights: Record Revenue Surge and ...
5 de agosto ·
SeekingAlpha
Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary
4 de agosto ·
SeekingAlpha
Janus Henderson Global Life Sciences Fund Q2 2025 Commentary
31 de julho ·
SeekingAlpha
Alnylam: Amvuttra Is Just Getting Started
31 de julho ·
Yahoo
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
29 de julho ·
Yahoo
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?
25 de julho ·
Yahoo
Truist Sees Upside in BridgeBio Pharma’s (BBIO) ATTR-CM Strategy
23 de julho ·
Yahoo
Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1
22 de julho ·
Yahoo
BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET

1

2

1

2

BridgeBio Pharma Ações Comunicados de Imprensa

BridgeBio Pharma publica regularmente na página da empresa notícias que são relevantes para os investidores.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Assinatura por 2 € / mês

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan